Table 1.
Comparison of Baseline Demographic and Disease-Related Characteristics by Group (n = 84)
Characteristic | Western medicine (n = 54) | Combined treatment (n = 30) | p-Value |
---|---|---|---|
Mean age ± SD (yr) | 61.33 ± 11.12 | 58.31 ± 10.79 | 0.236a |
Sex | |||
Male | 35 (64.8) | 22 (73.3) | 0.423 |
Female | 19 (35.2) | 8 (26.7) | |
Marital status | |||
Single | 2 (3.7) | 2 (6.7) | 0.742b |
Married | 48 (88.9) | 24 (80.0) | |
Divorced | 1 (1.9) | 1 (3.3) | |
Widow/widower | 3 (5.6) | 3 (10.0) | |
Education | |||
Junior high | 39 (72.2) | 14 (46.7) | 0.055 |
High school | 10 (18.5) | 9 (30.0) | |
College | 5 (9.3) | 7 (23.3) | |
Employed | |||
No | 39 (72.2) | 19 (63.3) | 0.550 |
Yes | 15 (27.8) | 11 (36.7) | |
Economic status | |||
Insufficient | 22 (40.7) | 8 (26.7) | 0.189b |
Moderate | 27 (50.0) | 20 (66.7) | |
Sufficient | 5 (9.3) | 2 (6.7) | |
Comorbidity | |||
No | 23 (42.6) | 15 (50.0) | 0.671 |
Yesc | 31 (57.4) | 15 (50.0) | |
Lung cancer type | |||
Adenocarcinoma | 42 (80.8) | 18 (60.0) | 0.214b |
Large-cell carcinoma | 1 (1.9) | 0 (0.0) | |
Squamous-cell carcinoma | 8 (15.4) | 10 (33.3) | |
Non–small-cell carcinoma | 1 (1.9) | 2(6.7) | |
Missing | 2 | 0 | |
Stage of cancer | |||
IIIA | 3 (5.7) | 4 (13.3) | 0.206b |
IIIB | 12 (22.6) | 10 (33.3) | |
IV | 38 (71.7) | 16 (53.3) | |
Missing | 1 | 0 | |
Western therapy | |||
Chemotherapy | 27 (50.9) | 18 (60.0) | 0.690b |
Chemotherapy + radiation therapy | 12 (22.6) | 7 (23.3) | |
Targeted therapy | 8 (15.1) | 4 (13.3) | |
Chemotherapy + targeted therapy | 3 (5.7) | 0 (0.0) | |
Targeted therapy + radiation therapy | 3 (5.7) | 1 (3.3) | |
Missing | 1 | 0 | |
Chemotherapy | |||
Docetaxel + cisplatin | 16 (43.2) | 15 (60.0) | 0.09b |
Gemcitabine | 2 (5.4) | 2 (8.0) | |
Pemetrexed disodium + cisplatin | 7 (18.9) | 2 (8.0) | |
Oral vinorelbine + cisplatin | 4 (10.8) | 3 (12.0) | |
Docetaxel | 8 (21.) | 0 (0.0) | |
Gemcitabine + cisplatin | 0 (0.0) | 3 (12.0) | |
Missing | 5 | 0 |
Unless otherwise noted, values are number (percentage).
Independent t-test.
Fisher exact test.
Comorbidities include hypertension and diabetes mellitus.
SD, standard deviation.